Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Peters

Showing results (1201-1210 of 1,336) with videos related to

Pageof 134
Sort By:
European Heart Journal. Digital Health|February 4, 2026
Safety and effectiveness of remote monitoring and prioritization of patients awaiting transcatheter aortic valve implantation: a propensity-matched prospective observational cohort studyMihir A Kelshiker, Karanjot Chhatwal, Patrik Bachtiger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2024
Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapyD Daoudlarian, A Segot, S Latifyan, et al.
Heart Rhythm O2|May 25, 2026
Peak QRS/T ratio and the spatial ventricular gradient differentiate acute vs chronic left bundle branch block after transcatheter aortic valve replacementJonathan W Waks, Marie-France Poulin, Patricia Tung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2021
Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331<sup>☆</sup>D R Spigel, D Vicente, T E Ciuleanu, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trialS Peters, E Felip, U Dafni, et al.
ESMO Open|April 10, 2022
Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trialsD König, S Schär, D Vuong, et al.
Diabetes|October 17, 2024
Exploring Structural and Molecular Features of Sciatic Nerve Lesions in Diabetic Neuropathy: Unveiling Pathogenic Pathways and TargetsDaniel Schwarz, Maxime Le Marois, Volker Sturm, et al.
Journal of the American Heart Association|April 12, 2023
Ventricular Conduction Stability Noninvasively Identifies an Arrhythmic Substrate in Survivors of Idiopathic Ventricular FibrillationJi-Jian Chow, Kevin M W Leong, Matthew J Shun-Shin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2021
Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancerA J Schoenfeld, S J Antonia, M M Awad, et al.
JCO Precision Oncology|July 29, 2021
Loss of <i>SNAI2</i> in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation TherapyMarek Cmero, Natalie J Kurganovs, Ryan Stuchbery, et al.
Pageof 134

Showing results (1201-1210 of 1,336) with videos related to

Sort By:
Pageof 134
European Heart Journal. Digital Health|February 4, 2026
Safety and effectiveness of remote monitoring and prioritization of patients awaiting transcatheter aortic valve implantation: a propensity-matched prospective observational cohort studyMihir A Kelshiker, Karanjot Chhatwal, Patrik Bachtiger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2024
Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapyD Daoudlarian, A Segot, S Latifyan, et al.
Heart Rhythm O2|May 25, 2026
Peak QRS/T ratio and the spatial ventricular gradient differentiate acute vs chronic left bundle branch block after transcatheter aortic valve replacementJonathan W Waks, Marie-France Poulin, Patricia Tung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2021
Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331<sup>☆</sup>D R Spigel, D Vicente, T E Ciuleanu, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trialS Peters, E Felip, U Dafni, et al.
ESMO Open|April 10, 2022
Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trialsD König, S Schär, D Vuong, et al.
Diabetes|October 17, 2024
Exploring Structural and Molecular Features of Sciatic Nerve Lesions in Diabetic Neuropathy: Unveiling Pathogenic Pathways and TargetsDaniel Schwarz, Maxime Le Marois, Volker Sturm, et al.
Journal of the American Heart Association|April 12, 2023
Ventricular Conduction Stability Noninvasively Identifies an Arrhythmic Substrate in Survivors of Idiopathic Ventricular FibrillationJi-Jian Chow, Kevin M W Leong, Matthew J Shun-Shin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2021
Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancerA J Schoenfeld, S J Antonia, M M Awad, et al.
JCO Precision Oncology|July 29, 2021
Loss of <i>SNAI2</i> in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation TherapyMarek Cmero, Natalie J Kurganovs, Ryan Stuchbery, et al.
Pageof 134